Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Indu Lal
Summit Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
253 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Uc Louvain Namur
Louvain-la-Neuve, Belgium
Recruiting - Az Glorieux
Ronse, Belgium
Recruiting
- London Regional (lrcp)
London, Ontario, Canada
Recruiting - Ottawa Cancer Center
Ottawa, Ontario, Canada
Recruiting - Saskatchewan Cancer
Regina, Saskatchewan, Canada
Recruiting
- Fu Yang People'S Hospital
Yangzhou, Anhui, China
Recruiting - Beijing Chest Hospital
Tongzhou, Beijing Municipality, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Gansu Provincial Cancer Hospital
Lanzhou, Gansu, China
Recruiting - Fujian Cancer Hospital
Guangzhou, Guangdong, China
Recruiting - the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Recruiting - Hainan General Hospital
Haikou, Hainan, China
Recruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Recruiting - Henan University of Science and Technology Affiliated Anyang Cancer Hospital
Anyang, Henan, China
Recruiting - Nanyang Central Hospital
Nanyang, Henan, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Yangtze University
Jingzhou, Hubei, China
Recruiting - Xiangyang Central Hospital
Xiangyang, Hubei, China
Recruiting - Hunan Cancer Hospital Thoracic Medicine 1
Changsha, Hunan, China
Recruiting - Xiangya Hospital of Central South University
Changsha, Hunan, China
Recruiting - the First Affiliated Hospital of University of South China
Hengyang, Hunan, China
Recruiting - the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Recruiting - the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Recruiting - First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangxi, China
Recruiting - Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
Recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting - Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Recruiting - the Second Affiliated Hospital of Afmu
Xi'an, Shaanxi, China
Recruiting - the First Affiliated Hospital of Xi'An Jiao Tong University
Xi'an, Shaanxi, China
Recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Recruiting - Linyi People'S Hospital
Linyi, Shandong, China
Recruiting - Qingdao Central Hospital
Qingdao, Shandong, China
Recruiting - Fudan University Shanghai Cancer Center
Xuhui, Shanghai Municipality, China
Recruiting - Shanghai Chest Hospital
Xuhui, Shanghai Municipality, China
Recruiting - Shanghai Pulmonary Hospital
Yangpu, Shanghai Municipality, China
Recruiting - Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
Recruiting - Mianyang Central Hospital
Mianyang, Sichuan, China
Recruiting - Cancer Hospital Affiliated To Xinjiang Medical University
Ürümqi, Xinjiang, China
Recruiting - Yunnan Cancer Hospital
Kunming, Yunnan, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Oct 2023
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2029
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 1,600
- Registry id
- NCT05899608
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.